Trials / Completed
CompletedNCT00282919
A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria
A Phase 2, Open Label, Non-Comparative Trial Of Azithromycin 2000 mg Plus Chloroquine 600 Mg Base Daily For Three Days For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The treatment of symptomatic, uncomplicated malaria caused by P. falciparum in adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin plus chloroquine | dose of 2000 mg Azithromycin plus 600 mg chloroquine base |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2006-01-27
- Last updated
- 2014-06-26
- Results posted
- 2014-06-26
Locations
2 sites across 2 countries: Colombia, India
Source: ClinicalTrials.gov record NCT00282919. Inclusion in this directory is not an endorsement.